Cyclopentadecanone, 3-methyl-, (3R)-
| Common Name: |
Cyclopentadecanone, 3-methyl-, (3R)- |
| IUPAC Name: |
(3R)-3-methylcyclopentadecan-1-one |
| Molecular Formula: |
C6H14OS |
| SMILES: |
CC1CCCCCCCCCCCCC(=O)C1 |
| Inchi: |
1S/C16H30O/c1-15-12-10-8-6-4-2-3-5-7-9-11-13-16(17)14-15/h15H,2-14H2,1H3/t15-/m1/s1 |
| Inchi Key: |
ALHUZKCOMYUFRB-OAHLLOKOSA-N |
| Cas No: |
10403-00-6 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
1 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
134.24 |
| Mass (g/mol) |
238.23 |
| Molar Refractivity |
40.05 |
| Net Charge |
|
| HBD |
1 |
| HBA |
1 |
| Rt Bonds |
4 |
| Rings |
1 |
| TPSA |
59.03 |
| Hetero Atoms |
1 |
| Heavy Atoms |
8 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
|
| Vapor Pressure (mmHg@25.00 °C) |
|
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
1.00 |
| LogP |
5.277 |
| iLOGP |
1.85 |
| XLOGP3 |
1.50 |
| WLOGP |
1.47 |
| MLOGP |
1.53 |
| ESOL Log S |
-1.35 |
| ESOL Solubility (mg/ml) |
5.95 |
| ESOL Solubility (mol/l) |
0.044 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-2.35 |
| Ali Solubility (mg/ml) |
0.6 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-1.44 |
| Silicos-IT Solubility (mg/ml) |
4.91 |
| Silicos-IT Solubility (mol/l) |
0.04 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.05 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.671 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.823 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
